Expression of Toll-like receptors in chronic hepatitis C virus infection (Q45400164)

14 December 2017

Expression of Toll-like receptors in chronic hepatitis C virus infection (English)

1 reference

14 December 2017

0 references

1 reference

1 reference

1 reference

1 reference

Ken Sato

1

1 reference

14 December 2017

Tetsuya Ishikawa

2

1 reference

14 December 2017

Akihiko Okumura

3

1 reference

14 December 2017

Taeko Yamauchi

4

1 reference

14 December 2017

Sayaka Sato

5

1 reference

14 December 2017

Minoru Ayada

6

1 reference

14 December 2017

Eiji Matsumoto

7

1 reference

14 December 2017

Naoki Hotta

8

1 reference

14 December 2017

Tomohiko Oohashi

9

1 reference

14 December 2017

Yoshitaka Fukuzawa

10

1 reference

14 December 2017

Shinichi Kakumu

11

1 reference

14 December 2017

1 October 2007

1 reference

Journal of Gastroenterology and Hepatology

14 December 2017

1 reference

14 December 2017

22

1 reference

14 December 2017

10

1 reference

14 December 2017

1627-1632

1 reference

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

14 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04783.X

Toll-like receptors and innate antiviral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04783.X

The potential for Toll-like receptors to collaborate with other innate immune receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04783.X

Innate sensing of viruses by toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04783.X

Toll-like receptors in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04783.X

Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04783.X

Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04783.X

Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04783.X

Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04783.X

Interferon regulatory factor 3-independent double-stranded RNA-induced inhibition of hepatitis C virus replicons in human embryonic kidney 293 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04783.X

Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04783.X

Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04783.X

Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04783.X

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04783.X

A comprehensive view of regulation of gene expression by double-stranded RNA-mediated cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04783.X

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04783.X

Cell type-specific involvement of RIG-I in antiviral response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04783.X

Evasion of intracellular host defence by hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04783.X

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04783.X

Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04783.X

Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04783.X

Hepatitis C virus core protein induces apoptosis and impairs cell-cycle regulation in stably transformed Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04783.X

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04783.X

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04783.X

10.1111/J.1440-1746.2006.04783.X

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference